Abstract:Abstract Background The location and number of involved sub-segments in small bowel Crohn’s disease (CD) vary on each patient. This study aimed to evaluate the distribution and characteristics of involved small intestine lesions through a detailed image review at the time of diagnosis and to evaluate the relationship between them and clinical outcomes. Methods CD patients who underwent computed tomography (CT) at the initial diagnosis were retrospectively enrolled. Two abdominal radiologists reviewed the CT images of all patients. They independently rated the presence of “bowel wall thickening”, “stricture”, and “fistula or abscess” in the jejunum, distal jejunum/proximal ileum, ileum, and terminal ileum, respectively. Score 1 was assigned if both radiologists concurred regarding the presence of a lesion. Based on the total score summed across different locations in the small bowel (e.g., imaging score), we divided the patients into three groups as 0, 1–2, and 3–4. Major clinical outcomes were compared among these groups. Results A total of 152 patients were enrolled. The proportion of the patients involved in the jejunum, distal jejunum/proximal ileum, ileum, and terminal ileum was 2.0%, 30.3%, 82.2%, and 71.7%, respectively; 32.3% of the patients had Montreal classification L4 (involvement of jejunum or distal jejunum/proximal ileum). Agreement on fistula or abscess was almost perfect (kappa value = 1.0 for most segments); the degree of agreement on bowel wall thickness and stricture varied according to involved segments (kappa value = 0.690–0.936). There were 15 (9.9%), 100 (65.8%), and 37 (24.3%) patients in groups 0, 1–2, and 3–4, respectively. In Kaplan-Meier survival analysis, there was no difference in the major clinical outcomes among three groups based on the imaging score (emergency room visit p = 0.093; operation p = 0.080; new use of corticosteroid p = 0.139; and new use of biologics p = 0.126). In the multivariable analysis, disease behavior was the only risk factor associated with all clinical outcomes after adjusting other factor (emergency room visit, HR 2.127 [1.356–3.337], p = 0.001; operation, HR 8.216 [2.629–25.683], p < 0.001; new use of corticosteroid, HR 1.816 [1.249–2.642], p =0.002; and new use of biologics, HR 2.352 [1.492–3.708], p < 0.001). Conclusion As a result of a detailed CT review, about one-third and one-fourth of patients newly diagnosed as small bowel CD had L4 lesions and multiple lesions (> 2 segments), respectively. However, the location and number of involved sub-segments in small bowel CD did not affect the clinical outcomes. Initial disease behavior is a more critical factor associated with clinical outcomes than characteristics of disease location.

Small bowel Crohn's disease: Proximal lesions linked to increased inflammation and biologic treatment needs

Characteristics and Prognosis of Isolated Small-Bowel Crohn’s Disease

Differentiation of Isolated Small Bowel Crohn's Disease from Other Small Bowel Ulcerative Diseases: Clinical Features and Double-Balloon Enteroscopy Characteristics.

P457 Small bowel involvement proximal to the terminal ileum is a major risk factor for intestinal resection in patients with small bowel Crohn’s disease

P123 Characteristics of small bowel involvement and association with clinical outcome in patients with Crohn’s disease

The utility of capsule endoscopy in the phenotype of Crohn's disease. Data from England 2016-2021

Effect of Crohn’s Disease on Villous Length and CYP3A4 Expression in the Pediatric Small Intestine

Effect of Crohn's Disease on Villous Length and CYP3A4 Expression in the Pediatric Small Intestine

P207 It’s time to include capsule endoscopy to assess mucosal activity as part of the ‘treat-to-target’ strategy in Crohn’s disease: a real-life experience from a reference center in Argentina

Fecal calprotectin as an inflammatory biomarker in small bowel Crohn disease

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Capsule endoscopy findings for the diagnosis of Crohn's disease: a nationwide case-control study

Long-Term Monitoring and Clinical Implications of Small Bowel Capsule Endoscopy in Patients with Crohn's Disease with Small Bowel Lesions: A Retrospective Analysis

Small Bowel Cancer in Crohn's Disease

Clinical Features of Crohn's Disease at Different Location

Biologics, small molecule therapies and surgery in small bowel Crohn's disease

P405 Intestinal ultrasound measures are highly correlated with small bowel Lewis score among patients with active Crohn’s disease

Serum Analyte Profiles Associated With Crohn's Disease and Disease Location

Small intestine imaging manifestations and diagnostic key points of Crohn's disease

The Prevalence of Concomitant Skip Small Bowel Lesions in Crohn’s Disease and Their Effects on Reoperation in Patients Undergoing Ileocolic Resection

P491 Clinical application of ICCE criteria for suspected Crohn’s disease undergoing small bowel capsule endoscopy